CSL Limited falls after Phase 3 setback for key trial
https://seekingalpha.com/news/4065708-csl-limited-stock-falls-after-phase-3-setback?source=feed_sector_healthcare
Feb 12, 2024 - Australian biotech CSL Limited (CSLLY) experienced a 4% intraday loss after its Phase 3 AEGIS-II trial, aimed at reducing cardiovascular events, failed.
0
Carlisle (CSL) Q4 Earnings Beat Estimates, Revenues Decline Y/Y
https://www.zacks.com/stock/news/2222679/carlisle-csl-q4-earnings-beat-estimates-revenues-decline-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2222679
Feb 07, 2024 - Carlisle (CSL) fourth-quarter 2023 results benefit from higher revenues across the Carlisle Construction Materials segment.
0
Compared to Estimates, Carlisle (CSL) Q4 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2222223/compared-to-estimates-carlisle-csl-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2222223
Feb 06, 2024 - Although the revenue and EPS for Carlisle (CSL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Carlisle (CSL) Q4 Earnings and Revenues Beat Estimates
https://www.zacks.com/stock/news/2222152/carlisle-csl-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2222152
Feb 06, 2024 - Carlisle (CSL) delivered earnings and revenue surprises of 20.17% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Will Carlisle (CSL) Beat Estimates Again in Its Next Earnings Report?
https://www.zacks.com/stock/news/2220462/will-carlisle-csl-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2220462
Feb 02, 2024 - Carlisle (CSL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Insights Into Carlisle (CSL) Q4: Wall Street Projections for Key Metrics
https://www.zacks.com/stock/news/2220202/insights-into-carlisle-csl-q4-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220202
Feb 02, 2024 - Besides Wall Street's top -and-bottom-line estimates for Carlisle (CSL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
0
Reasons to Add Carlisle (CSL) Stock to Your Portfolio Now
https://www.zacks.com/stock/news/2206221/reasons-to-add-carlisle-csl-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2206221
Jan 05, 2024 - Carlisle (CSL) is set to benefit from strength across its businesses, acquired assets and initiatives to drive operational excellence.
0
ITT Gains More Than 38% in a Year: Will the Growth Continue?
https://www.zacks.com/stock/news/2205784/itt-gains-more-than-38-in-a-year-will-the-growth-continue?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2205784
Jan 04, 2024 - Strength in the aftermarket business within the Industrial Process segment bodes well for ITT. The company's measures to reward its shareholders are impressive.
0
Here is Why Growth Investors Should Buy Carlisle (CSL) Now
https://www.zacks.com/stock/news/2205216/here-is-why-growth-investors-should-buy-carlisle-csl-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_11_growth-2205216
Jan 03, 2024 - Carlisle (CSL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
0
Zacks.com featured highlights include NRG Energy, Carlisle Companies, Arch Resources, Cboe Global Markets and Arch Capital Group
https://www.zacks.com/stock/news/2204846/zacks-com-featured-highlights-include-nrg-energy-carlisle-companies-arch-resources-cboe-global-markets-and-arch-capital-group?cid=CS-ZC-FT-press_releases-2204846
Jan 03, 2024 - NRG Energy, Carlisle Companies, Arch Resources, Cboe Global Markets and Arch Capital Group are part of the Zacks Screen of the Week article.
0